Can efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, Viraday) treat AIDS (HIV)?

Efavirenz/Emtricitabine/Tenofovir (EFV+FTC+TDF, Viraday) can treat AIDS (HIV).

Efavirenz/Emtricitabine/Tenofovir is a compound antiretroviral drug composed of efavirenz (EF It consists of three ingredients: V), emtricitabine (FTC), and tenofovir (TDF). These three ingredients belong to the non-nucleoside reverse transcriptase inhibitor (NNRTI) and nucleoside reverse transcriptase inhibitor (NRTI) classes of drugs respectively.

Through the synergistic effect of these three ingredients, efavirenz/emtricitabine/tenofovir can effectively inhibit the replication and spread of HIV viruses, thereby controlling HIV infection and slowing down the progression of the virus, and helping patients maintain good immune function. Long-term and correct use of Viraday can maintain the viral load at a low level, delay the development of AIDS, improve the patient's quality of life, and extend lifespan.

However, it is worth noting that efavirenz/emtricitabine/tenofovir does not cure AIDS, it can only help patients control the disease and maintain good immune function. Therefore, patients should continue to conduct regular monitoring and follow-up when using efavirenz/emtricitabine/tenofovir, and follow the doctor's guidance and treatment plan to ensure optimal efficacy and safety. If any discomfort or adverse reaction occurs during the use of efavirenz/emtricitabine/tenofovir, you should report it to your doctor immediately and make timely adjustments and management.

Efavirenz/Emtricitabine/Tenofovir (EFV+FTC+TDF, Viraday) is not currently on the market in China, so patients cannot purchase it domestically and need to purchase it through overseas purchasing channels. The cheaper ones abroad are mainly Indian generic drugs, which cost around 380 yuan.